Condition: Obstructive Sleep Apnea (OSA) · Sponsor: XII Medical
The goal of this interventional study is to assess the safety and performance of the XII Medical Hypoglossal Nerve Stimulation (HGNS) System in people who have moderate to severe Obstructive Sleep Apnea (OSA). Participation in this study involves being implanted with a Neurostimulator which provides electrical stimulation of the hypoglossal nerve (HGN). Participants will receive treatment at home during sleep, and participate in sleep studies to track and record the quality of the sleep. Participants will be monitored over the course of the study.
This description comes directly from the study's public registry record.
Professor Stuart MacKay FRACS · +61 2 4226 1055 · reception@illawarraent.com.au
Always discuss trial participation with your own doctor first.
| Canberra ENT | Canberra, Australian Capital Territory, Australia | Recruiting |
| Westmead Hospital / Chris O'Brien Lifehouse | Sydney, New South Wales, Australia | Recruiting |
| The Wollongong Hospital | Wollongong, New South Wales, Australia | Recruiting |
| Princess Alexandra Hospital | Brisbane, Queensland, Australia | Recruiting |
| Perth Head & Neck Surgery | Perth, Western Australia, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07049744